Merit Medical Sys (MMSI) 19.53 $MMSI
Merit Medical to Present at UBS Global Healthcare Conference
GlobeNewswire - Thu May 12, 8:00AM CDT
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate at the UBS Global Healthcare Conference being held May 23-25 at the Grand Hyatt New York.
MMSI: 19.53 (+0.55)
Merit Medical Appointed Global Distributor for Micro Guide Wire
GlobeNewswire - Tue May 10, 8:30AM CDT
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it has signed a distribution deal with PIOLAX Medical Devices, Inc. of Yokohama, Japan for a product known in Japan as the Labyrinth Noah(TM) Micro Guide Wire. The deal covers all global markets, with the exception of Japan, and is subject to certain minimum order requirements.
MMSI: 19.53 (+0.55)
Merit Medical meets 1Q profit forecasts
Automated Insights - Thu Apr 28, 6:44PM CDT
SOUTH JORDAN, Utah (AP) _ Merit Medical Systems Inc. (MMSI) on Thursday reported first-quarter profit of $4.4 million.
MMSI: 19.53 (+0.55)
Merit Medical Reports Sales Up 6.6% for the Quarter Ended March 31, 2016
GlobeNewswire - Thu Apr 28, 3:00PM CDT
-- Q1 revenue of $138.1 million ($140.0 million in constant currency), up 6.6% as reported, up 8.0% on a comparable, constant currency basis
MMSI: 19.53 (+0.55)
Merit Medical Systems to Announce First Quarter Results on April 28, 2016
GlobeNewswire - Mon Apr 04, 8:30AM CDT
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that the Company will release its financial results for the first quarter ended March 31, 2016, after the close of the stock market on Thursday, April 28, 2016.
MMSI: 19.53 (+0.55)
Merit Medical Announces 510(k) Clearance for Corvocet(TM) Biopsy System
GlobeNewswire - Mon Mar 28, 8:30AM CDT
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it received notification of substantial equivalence from the FDA for the Corvocet(TM) Biopsy System, which is intended for use in obtaining core biopsy samples from the liver, kidney, prostate, breast, lung and various other soft tissue tumors.
MMSI: 19.53 (+0.55)
Merit Medical Systems Shares Down 10.4% Since SmarTrend's Sell Call (MMSI)
Comtex SmarTrend(R) - Fri Feb 19, 4:59PM CST
SmarTrend identified a Downtrend for Merit Medical Systems (NASDAQ:MMSI) on October 23rd, 2015 at $20.09. In approximately 4 months, Merit Medical Systems has returned 10.40% as of today's recent price of $18.00.
MMSI: 19.53 (+0.55)
Becton, Dickinson's Blood Collection Set Receives FDA Nod
Zacks Equity Research - Zacks Investment Research - Fri Feb 19, 2:05PM CST
Becton, Dickinson and Company (BDX) recently announced that its new BD Vacutainer UltraTouch Push Button Blood Collection Set has received FDA approval as well as European CE marking.
BDX: 172.19 (+2.22), STAA: 5.62 (+0.36), PDCO: 48.46 (+0.56), MMSI: 19.53 (+0.55)
Merit Medical to Present at Four Conferences
GlobeNewswire - Wed Feb 10, 8:30AM CST
RBC Capital Markets - February 24
MMSI: 19.53 (+0.55)
Global Non-vascular Stents Market 2016-2020 with Boston Scientific, Cook Medical, C.R. Bard & Medtronic Dominating
M2 - Mon Feb 08, 11:09AM CST
Research and Markets (http://www.researchandmarkets.com/research/lhzzfb/global) has announced the addition of the "Global Non-vascular Stents Market 2016-2020" report to their offering. The global non-vascular stents market to grow at a CAGR of 5.24% during the period 2016-2020. Global Non-vascular Stents Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Advances in technology have resulted in the introduction of stents in a wide range of sizes, designs, and materials. A typical gastrointestinal or urologic stent is about 18 cm. There are other micro stents available for different stent applications. The use of biodegradable polymer in non-vascular stents has the advantages of biocompatibility and eliminating the need for stent removal. According to the report, the increased incidence of gastrointestinal disorders such as colon cancer, rectal cancer, and other urological conditions, coupled with the aging population, is driving market growth. Further, the report states that complications associated with non-vascular stents restricts the market growth. To calculate the market size, the report considers the revenue generated from the sales of non-vascular stents, which are segmented as follows: - Gastrointestinal stents - Urological stents - Pulmonary stents Key vendors - Boston Scientific - Cook Medical - C.R. Bard - Medtronic Other prominent vendors - Allium Medical - EFER Endoscopy - Amecath - Applied Medical - BIOTEQ - BVM Medical - Coloplast - ConMed - ELLA-CS - EndoChoice - Hobbs Medical - Merit Endotek - Merit Medical Systems - Novatech - Olympus - Surgimedik - Taewoong Medical - Xlumena For more information visit http://www.researchandmarkets.com/research/lhzzfb/global
BSX: 22.97 (+0.31), MDT: 85.77 (+1.51), MMSI: 19.53 (+0.55)
Merit Medical Systems Down 21.8% Since SmarTrend Downtrend Call (MMSI)
Comtex SmarTrend(R) - Fri Feb 05, 6:07PM CST
SmarTrend identified a Downtrend for Merit Medical Systems (NASDAQ:MMSI) on October 23rd, 2015 at $20.09. In approximately 4 months, Merit Medical Systems has returned 21.75% as of today's recent price of $15.72.
MMSI: 19.53 (+0.55)
Merit Medical Systems to Announce Fourth Quarter and Year End Results on February 22, 2016
GlobeNewswire - Thu Feb 04, 3:00PM CST
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that the Company will release its financial results for the fourth quarter and year ended December 31, 2015, after the close of the stock market on Monday, February 22, 2016.
MMSI: 19.53 (+0.55)
Merit Medical Acquires the HeRO(R)Graft From CryoLife, Inc.
GlobeNewswire - Thu Feb 04, 10:04AM CST
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, today announced that it has purchased the HeRO(R)Graft device and related assets from CryoLife, Inc.
CRY: 11.94 (+0.09), MMSI: 19.53 (+0.55)
CryoLife Announces Sale of HeRO Graft to Merit Medical Systems
PR Newswire - Thu Feb 04, 7:04AM CST
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that it sold its HeRO Graft product line to Merit Medical Systems, Inc. (NASDAQ: MMSI) for $18.5 million in cash.
CRY: 11.94 (+0.09), MMSI: 19.53 (+0.55)
Catheter Stabilization Device/Catheter Securement Devices Market (2015-2020) - Increasing Healthcare Expenditure Driving Growth
M2 - Thu Jan 28, 5:39AM CST
Research and Markets (http://www.researchandmarkets.com/research/hkxh94/catheter) has announced the addition of the "Catheter Stabilization Device/Catheter Securement Devices Market - Global Forecast to 2020" report to their offering. The global catheter stabilization device market is expected to reach $1,372.35 Million by 2020 from $957.26 Million in 2015, growing at a CAGR of 7.47% between 2015 and 2020. Increasing healthcare expenditures and demand for minimal invasive surgeries will drive the growth of the securement devices market. This report segments the global catheter stabilization device market by products, applications and end users. The global market product segments included in the report comprises of arterial securement devices, central venous catheter securement device, peripheral securement devices, abdominal drainage tubes securement devices, epidural securement devices, chest drainage tube securement devices, and all-site devices. The geographic segments included in this report are North America, Europe, Asia and Rest of the World (RoW). The geographic analysis reveals that North America accounted for the largest share in the global securement devices market in 2015. Asia regional segment, on the other hand, is expected to register a faster growth from 2015 to 2020, due to the increasing healthcare expenditure and aging population from this region. Companies Mentioned: - 3M Company - B. Braun Melsungen Ag - Baxter International, Inc. - C. R. Bard, Inc. - Centurion Medical Products - Convatec, Inc. - M. C. Johnson Company, Inc. - Medtronic PLC - Merit Medical Systems, Inc. - Smiths Group PLC Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Catheter Stabilization Device Market, By Product 7 Catheter Stabilization Device Market, By End User 8 Catheter Stabilization Device Market, By Application 9 Geographic Analysis 10 Competitive Landscape 11 Company Profiles For more information visit http://www.researchandmarkets.com/research/hkxh94/catheter
MMM: 174.11 (+2.88), MDT: 85.77 (+1.51), BAX: 45.96 (+1.02), MMSI: 19.53 (+0.55)
Merit Medical to Present at UBS Global Healthcare Conference
GlobeNewswire - Thu May 12, 8:00AM CDT
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate at the UBS Global Healthcare Conference being held May 23-25 at the Grand Hyatt New York.
MMSI: 19.53 (+0.55)
Merit Medical Appointed Global Distributor for Micro Guide Wire
GlobeNewswire - Tue May 10, 8:30AM CDT
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it has signed a distribution deal with PIOLAX Medical Devices, Inc. of Yokohama, Japan for a product known in Japan as the Labyrinth Noah(TM) Micro Guide Wire. The deal covers all global markets, with the exception of Japan, and is subject to certain minimum order requirements.
MMSI: 19.53 (+0.55)
Merit Medical meets 1Q profit forecasts
Automated Insights - Thu Apr 28, 6:44PM CDT
SOUTH JORDAN, Utah (AP) _ Merit Medical Systems Inc. (MMSI) on Thursday reported first-quarter profit of $4.4 million.
MMSI: 19.53 (+0.55)
Merit Medical Reports Sales Up 6.6% for the Quarter Ended March 31, 2016
GlobeNewswire - Thu Apr 28, 3:00PM CDT
-- Q1 revenue of $138.1 million ($140.0 million in constant currency), up 6.6% as reported, up 8.0% on a comparable, constant currency basis
MMSI: 19.53 (+0.55)
Merit Medical Systems to Announce First Quarter Results on April 28, 2016
GlobeNewswire - Mon Apr 04, 8:30AM CDT
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that the Company will release its financial results for the first quarter ended March 31, 2016, after the close of the stock market on Thursday, April 28, 2016.
MMSI: 19.53 (+0.55)
Merit Medical Announces 510(k) Clearance for Corvocet(TM) Biopsy System
GlobeNewswire - Mon Mar 28, 8:30AM CDT
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it received notification of substantial equivalence from the FDA for the Corvocet(TM) Biopsy System, which is intended for use in obtaining core biopsy samples from the liver, kidney, prostate, breast, lung and various other soft tissue tumors.
MMSI: 19.53 (+0.55)
Merit Medical Systems Shares Down 10.4% Since SmarTrend's Sell Call (MMSI)
Comtex SmarTrend(R) - Fri Feb 19, 4:59PM CST
SmarTrend identified a Downtrend for Merit Medical Systems (NASDAQ:MMSI) on October 23rd, 2015 at $20.09. In approximately 4 months, Merit Medical Systems has returned 10.40% as of today's recent price of $18.00.
MMSI: 19.53 (+0.55)
Becton, Dickinson's Blood Collection Set Receives FDA Nod
Zacks Equity Research - Zacks Investment Research - Fri Feb 19, 2:05PM CST
Becton, Dickinson and Company (BDX) recently announced that its new BD Vacutainer UltraTouch Push Button Blood Collection Set has received FDA approval as well as European CE marking.
BDX: 172.19 (+2.22), STAA: 5.62 (+0.36), PDCO: 48.46 (+0.56), MMSI: 19.53 (+0.55)
Merit Medical to Present at Four Conferences
GlobeNewswire - Wed Feb 10, 8:30AM CST
RBC Capital Markets - February 24
MMSI: 19.53 (+0.55)
Global Non-vascular Stents Market 2016-2020 with Boston Scientific, Cook Medical, C.R. Bard & Medtronic Dominating
M2 - Mon Feb 08, 11:09AM CST
Research and Markets (http://www.researchandmarkets.com/research/lhzzfb/global) has announced the addition of the "Global Non-vascular Stents Market 2016-2020" report to their offering. The global non-vascular stents market to grow at a CAGR of 5.24% during the period 2016-2020. Global Non-vascular Stents Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Advances in technology have resulted in the introduction of stents in a wide range of sizes, designs, and materials. A typical gastrointestinal or urologic stent is about 18 cm. There are other micro stents available for different stent applications. The use of biodegradable polymer in non-vascular stents has the advantages of biocompatibility and eliminating the need for stent removal. According to the report, the increased incidence of gastrointestinal disorders such as colon cancer, rectal cancer, and other urological conditions, coupled with the aging population, is driving market growth. Further, the report states that complications associated with non-vascular stents restricts the market growth. To calculate the market size, the report considers the revenue generated from the sales of non-vascular stents, which are segmented as follows: - Gastrointestinal stents - Urological stents - Pulmonary stents Key vendors - Boston Scientific - Cook Medical - C.R. Bard - Medtronic Other prominent vendors - Allium Medical - EFER Endoscopy - Amecath - Applied Medical - BIOTEQ - BVM Medical - Coloplast - ConMed - ELLA-CS - EndoChoice - Hobbs Medical - Merit Endotek - Merit Medical Systems - Novatech - Olympus - Surgimedik - Taewoong Medical - Xlumena For more information visit http://www.researchandmarkets.com/research/lhzzfb/global
BSX: 22.97 (+0.31), MDT: 85.77 (+1.51), MMSI: 19.53 (+0.55)
Merit Medical Systems Down 21.8% Since SmarTrend Downtrend Call (MMSI)
Comtex SmarTrend(R) - Fri Feb 05, 6:07PM CST
SmarTrend identified a Downtrend for Merit Medical Systems (NASDAQ:MMSI) on October 23rd, 2015 at $20.09. In approximately 4 months, Merit Medical Systems has returned 21.75% as of today's recent price of $15.72.
MMSI: 19.53 (+0.55)
Merit Medical Systems to Announce Fourth Quarter and Year End Results on February 22, 2016
GlobeNewswire - Thu Feb 04, 3:00PM CST
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that the Company will release its financial results for the fourth quarter and year ended December 31, 2015, after the close of the stock market on Monday, February 22, 2016.
MMSI: 19.53 (+0.55)
Merit Medical Acquires the HeRO(R)Graft From CryoLife, Inc.
GlobeNewswire - Thu Feb 04, 10:04AM CST
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, today announced that it has purchased the HeRO(R)Graft device and related assets from CryoLife, Inc.
CRY: 11.94 (+0.09), MMSI: 19.53 (+0.55)
CryoLife Announces Sale of HeRO Graft to Merit Medical Systems
PR Newswire - Thu Feb 04, 7:04AM CST
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that it sold its HeRO Graft product line to Merit Medical Systems, Inc. (NASDAQ: MMSI) for $18.5 million in cash.
CRY: 11.94 (+0.09), MMSI: 19.53 (+0.55)
Catheter Stabilization Device/Catheter Securement Devices Market (2015-2020) - Increasing Healthcare Expenditure Driving Growth
M2 - Thu Jan 28, 5:39AM CST
Research and Markets (http://www.researchandmarkets.com/research/hkxh94/catheter) has announced the addition of the "Catheter Stabilization Device/Catheter Securement Devices Market - Global Forecast to 2020" report to their offering. The global catheter stabilization device market is expected to reach $1,372.35 Million by 2020 from $957.26 Million in 2015, growing at a CAGR of 7.47% between 2015 and 2020. Increasing healthcare expenditures and demand for minimal invasive surgeries will drive the growth of the securement devices market. This report segments the global catheter stabilization device market by products, applications and end users. The global market product segments included in the report comprises of arterial securement devices, central venous catheter securement device, peripheral securement devices, abdominal drainage tubes securement devices, epidural securement devices, chest drainage tube securement devices, and all-site devices. The geographic segments included in this report are North America, Europe, Asia and Rest of the World (RoW). The geographic analysis reveals that North America accounted for the largest share in the global securement devices market in 2015. Asia regional segment, on the other hand, is expected to register a faster growth from 2015 to 2020, due to the increasing healthcare expenditure and aging population from this region. Companies Mentioned: - 3M Company - B. Braun Melsungen Ag - Baxter International, Inc. - C. R. Bard, Inc. - Centurion Medical Products - Convatec, Inc. - M. C. Johnson Company, Inc. - Medtronic PLC - Merit Medical Systems, Inc. - Smiths Group PLC Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Catheter Stabilization Device Market, By Product 7 Catheter Stabilization Device Market, By End User 8 Catheter Stabilization Device Market, By Application 9 Geographic Analysis 10 Competitive Landscape 11 Company Profiles For more information visit http://www.researchandmarkets.com/research/hkxh94/catheter
MMM: 174.11 (+2.88), MDT: 85.77 (+1.51), BAX: 45.96 (+1.02), MMSI: 19.53 (+0.55)
